Ulrich M. Lauer

Otfried Müller Str. 10
Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 127 publications

Enhanced Antitumor Activity and Induction of Immunogenic Cell Death in NUT Carcinoma Cells by Combining Oncolytic Viruses with the Dual Inhibitor NEO2734.

Enhanced Antitumor Activity and Induction of Immunogenic Cell Death in NUT Carcinoma Cells by Combining Oncolytic Viruses with the Dual Inhibitor NEO2734.

Journal: Viruses

Published: January 15, 2026

Progress and challenges in the development of advanced pancreatic cancer organoids.

Progress and challenges in the development of advanced pancreatic cancer organoids.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 09, 2026

Primary Renal Neuroendocrine Tumor: Diagnostic Challenges in a Rare Entity-A Case Report.

Primary Renal Neuroendocrine Tumor: Diagnostic Challenges in a Rare Entity-A Case Report.

Journal: Current oncology (Toronto, Ont.)

Published: December 12, 2025

An ex vivo permissivity assay to assess replication of the oncolytic virus VSV-GP in patient-derived tumor samples.

An ex vivo permissivity assay to assess replication of the oncolytic virus VSV-GP in patient-derived tumor samples.

Journal: Oncogene

Published: November 04, 2025

Cardiac Metastases in Neuroendocrine Neoplasms: A Single-Center Experience of Clinical Characteristics and Outcomes.

Cardiac Metastases in Neuroendocrine Neoplasms: A Single-Center Experience of Clinical Characteristics and Outcomes.

Journal: Cancers

Published: October 31, 2025

Durable clinical and immunologic response to an off-the-shelf EWSR1-FLI1 peptide vaccine in metastatic Ewing sarcoma.

Durable clinical and immunologic response to an off-the-shelf EWSR1-FLI1 peptide vaccine in metastatic Ewing sarcoma.

Journal: NPJ precision oncology

Published: September 24, 2025

The oncolytic vesicular stomatitis virus VSV-GP shows profound oncolytic activity in NUT-carcinoma cell lines.

The oncolytic vesicular stomatitis virus VSV-GP shows profound oncolytic activity in NUT-carcinoma cell lines.

Journal: Molecular therapy. Oncology

Published: July 31, 2025

Targeting oncogenic fusion-driven NUT carcinoma with CRISPR-Cas9 genome editing.

Targeting oncogenic fusion-driven NUT carcinoma with CRISPR-Cas9 genome editing.

Journal: Molecular therapy. Oncology

Published: March 09, 2025

NUT carcinoma in children and adolescents: An analysis of the European Cooperative Study Group on pediatric rare tumors (EXPeRT).

NUT carcinoma in children and adolescents: An analysis of the European Cooperative Study Group on pediatric rare tumors (EXPeRT).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 11, 2025

Deciphering permissivity of human tumor ecosystems to oncolytic viruses.

Deciphering permissivity of human tumor ecosystems to oncolytic viruses.

Journal: Oncogene

Published: November 27, 2024

A novel pseudotype derived of the canine distemper virus for adapter-mediated lentiviral transduction in vivo.

A novel pseudotype derived of the canine distemper virus for adapter-mediated lentiviral transduction in vivo.

Journal: Molecular therapy. Methods & clinical development

Published: September 19, 2024

Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma.

Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma.

Journal: ESMO open

Published: August 01, 2024

Showing 1-12 of 127

Last Updated: 09/26/2026